I.F. Luescher

Discipline

Economies et finances (2) Anthropologie biologique (1)

Type de document

Articles (20)

Co-auteur

Date

Source

Mot-clé

T cells (14) Antigens (14) Cells (11) Mice (10) Expression (10) Patients (9) Melanoma (9) Patients (9) Animals (8) membrane (7) Antigenic determinants (7) Human beings (7) spectacle (6) cytotoxicité (6) ligne (6) Photoaffinity labeling (6) Complexes (6) Amino acid sequence (6) Plasmodium (5) Receptors (5) immunité (4) Context (4) Blockades (4) Labels (4) Immunity (4) Evaluation (4) Clone cells (4) Cancer--Patients (4) Blockade (4) Tax assessment (4)

Documents écrit par I.F. Luescher (20) | parle de I.F. Luescher (0)

Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses.
J. Matsuzaki et al. (2015)
PD-1 and Tim-3 regulate the expansion of tumor antigen-specific CD8⁺ T cells induced by melanoma vaccines.
J. Fourcade et al. (2014)
TSLP promotes influenza-specific CD8+ T-cell responses by augmenting local inflammatory dendritic cell function.
K. Yadava et al. (2013)
Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cells.
P. Baumgaertner et al. (2012)
CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1.
J. Fourcade et al. (2012)
A Novel HLA-B18 Restricted CD8+ T Cell Epitope Is Efficiently Cross-Presented by Dendritic Cells from Soluble Tumor Antigen.
R.Y. Zhao et al. (2012)
Basal and antigen-induced exposure of the proline-rich sequence in CD3ε.
J. de la Cruz et al. (2011)
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients.
J. Fourcade et al. (2010)
Tumor antigen-specific FOXP3+ CD4 T cells identified in human metastatic melanoma: peptide vaccination results in selective expansion of Th1-like counterparts.
C. Jandus et al. (2009)
PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patients.
J. Fourcade et al. (2009)
CD8beta knockout mice mount normal anti-viral CD8+ T cell responses--but why?
G.S. Angelov et al. (2009)
IL-12 controls cytotoxicity of a novel subset of self-antigen-specific human CD28+ cytolytic T cells.
C. Barbey et al. (2007)
Soluble MHC-peptide complexes induce rapid death of CD8+ CTL.
M. Cebecauer et al. (2005)
CD8beta endows CD8 with efficient coreceptor function by coupling T cell receptor/CD3 to raft-associated CD8/p56(lck) complexes.
A. Arcaro et al. (2001)
Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative.
B.M. Kessler et al. (1997)
Role of CD8 in aberrant function of cytotoxic T lymphocytes.
B. Kessler et al. (1997)
CD8 beta increases CD8 coreceptor function and participation in TCR-ligand binding.
V. Renard et al. (1996)
Differential T cell receptor photoaffinity labeling among H-2Kd restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative. Labeling of the alpha-chain correlates with J alpha segment usage.
P. Romero et al. (1993)
A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.
C. Traversari et al. (1992)
H-2Kd-restricted antigenic peptides share a simple binding motif.
P. Romero et al. (1991)